Electrolyte Disturbances in Chronic Alcohol-Use Disorder

To the Editor: We agree with Palmer and Clegg (Oct. 5 issue) 1 that improper treatment of hyponatremia in patients with liver disease can produce cerebral demyelination, as reported by us 2 and others. Moreover, another factor promoting demyelination is a hypoxic or anoxic episode before treatment o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2018-01, Vol.378 (2), p.202-204
Hauptverfasser: Achinger, Steven G, Ayus, Juan C, Parrish, Carol R, Shah, Neeral L, Kuchly, Benoït, Tiksrail, Amar, Baglioni, Piero, Palmer, Biff F, Clegg, Deborah J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To the Editor: We agree with Palmer and Clegg (Oct. 5 issue) 1 that improper treatment of hyponatremia in patients with liver disease can produce cerebral demyelination, as reported by us 2 and others. Moreover, another factor promoting demyelination is a hypoxic or anoxic episode before treatment of hyponatremia. 2 In animals with normonatremia, hypoxia produces demyelination. 3 However, a safe approach for the therapy of hyponatremic encephalopathy in patients with liver disease should be revisited. In our practice, we have used a 100-ml bolus of 3% saline rather than a continuous infusion. 4 This can be repeated one or two times in sequential fashion . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMc1714331